 | • レポートコード：D0804-14821 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己マトリックス誘発性軟骨形成の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己マトリックス誘発性軟骨形成の種類別市場規模（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-Co-グリコール酸（PGLA））、用途別市場規模（膝関節、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：JRI Orthopaedics Ltd、Matricel、B. Braun Melsungen、BioTissue、CartiHeal、Anika Therapeutics、Zimmer Biomet Holdings、Geistlich Pharma、Arthro-Kinetics、Smith & Nephew ・地域別グローバル市場分析 2015年-2020年 ・自己マトリックス誘発性軟骨形成の北米市場（アメリカ、カナダ、メキシコ） ・自己マトリックス誘発性軟骨形成のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己マトリックス誘発性軟骨形成のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己マトリックス誘発性軟骨形成の南米市場（ブラジル、アルゼンチン） ・自己マトリックス誘発性軟骨形成の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-Co-グリコール酸（PGLA） ・用途別分析：膝関節、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Autologous Matrix-induced Chondrogenesis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 125.6 million by 2025, from USD 104.6 million in 2019.
The Autologous Matrix-induced Chondrogenesis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autologous Matrix-induced Chondrogenesis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autologous Matrix-induced Chondrogenesis market has been segmented into:
Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly Lactic-Co-Glycolic Acid (PGLA)
By Application, Autologous Matrix-induced Chondrogenesis has been segmented into:
Knees Joint
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autologous Matrix-induced Chondrogenesis market presented in the report. This section sheds light on the sales growth of different regional and country-level Autologous Matrix-induced Chondrogenesis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autologous Matrix-induced Chondrogenesis market.
The report offers in-depth assessment of the growth and other aspects of the Autologous Matrix-induced Chondrogenesis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autologous Matrix-induced Chondrogenesis Market Share Analysis
Autologous Matrix-induced Chondrogenesis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autologous Matrix-induced Chondrogenesis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autologous Matrix-induced Chondrogenesis sales, revenue and market share for each player covered in this report.
The major players covered in Autologous Matrix-induced Chondrogenesis are:
JRI Orthopaedics Ltd
Matricel
B. Braun Melsungen
BioTissue
CartiHeal
Anika Therapeutics
Zimmer Biomet Holdings
Geistlich Pharma
Arthro-Kinetics
Smith & Nephew
Table of Contents
1 Autologous Matrix-induced Chondrogenesis Market Overview
1.1 Product Overview and Scope of Autologous Matrix-induced Chondrogenesis
1.2 Classification of Autologous Matrix-induced Chondrogenesis by Type
1.2.1 Global Autologous Matrix-induced Chondrogenesis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type in 2019
1.2.3 Hyaluronic Acid
1.2.4 Collagen
1.2.5 Polyethylene Glycol (PEG)
1.2.6 Poly Lactic-Co-Glycolic Acid (PGLA)
1.3 Global Autologous Matrix-induced Chondrogenesis Market by Application
1.3.1 Overview: Global Autologous Matrix-induced Chondrogenesis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Knees Joint
1.3.3 Other
1.4 Global Autologous Matrix-induced Chondrogenesis Market by Regions
1.4.1 Global Autologous Matrix-induced Chondrogenesis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autologous Matrix-induced Chondrogenesis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autologous Matrix-induced Chondrogenesis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autologous Matrix-induced Chondrogenesis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autologous Matrix-induced Chondrogenesis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autologous Matrix-induced Chondrogenesis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autologous Matrix-induced Chondrogenesis Status and Prospect (2015-2025)
2 Company Profiles
2.1 JRI Orthopaedics Ltd
2.1.1 JRI Orthopaedics Ltd Details
2.1.2 JRI Orthopaedics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 JRI Orthopaedics Ltd SWOT Analysis
2.1.4 JRI Orthopaedics Ltd Product and Services
2.1.5 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Matricel
2.2.1 Matricel Details
2.2.2 Matricel Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Matricel SWOT Analysis
2.2.4 Matricel Product and Services
2.2.5 Matricel Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.3 B. Braun Melsungen
2.3.1 B. Braun Melsungen Details
2.3.2 B. Braun Melsungen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 B. Braun Melsungen SWOT Analysis
2.3.4 B. Braun Melsungen Product and Services
2.3.5 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioTissue
2.4.1 BioTissue Details
2.4.2 BioTissue Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioTissue SWOT Analysis
2.4.4 BioTissue Product and Services
2.4.5 BioTissue Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.5 CartiHeal
2.5.1 CartiHeal Details
2.5.2 CartiHeal Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CartiHeal SWOT Analysis
2.5.4 CartiHeal Product and Services
2.5.5 CartiHeal Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Anika Therapeutics
2.6.1 Anika Therapeutics Details
2.6.2 Anika Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Anika Therapeutics SWOT Analysis
2.6.4 Anika Therapeutics Product and Services
2.6.5 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zimmer Biomet Holdings
2.7.1 Zimmer Biomet Holdings Details
2.7.2 Zimmer Biomet Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zimmer Biomet Holdings SWOT Analysis
2.7.4 Zimmer Biomet Holdings Product and Services
2.7.5 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Geistlich Pharma
2.8.1 Geistlich Pharma Details
2.8.2 Geistlich Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Geistlich Pharma SWOT Analysis
2.8.4 Geistlich Pharma Product and Services
2.8.5 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Arthro-Kinetics
2.9.1 Arthro-Kinetics Details
2.9.2 Arthro-Kinetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Arthro-Kinetics SWOT Analysis
2.9.4 Arthro-Kinetics Product and Services
2.9.5 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Smith & Nephew
2.10.1 Smith & Nephew Details
2.10.2 Smith & Nephew Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Smith & Nephew SWOT Analysis
2.10.4 Smith & Nephew Product and Services
2.10.5 Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autologous Matrix-induced Chondrogenesis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autologous Matrix-induced Chondrogenesis Players Market Share
3.2.2 Top 10 Autologous Matrix-induced Chondrogenesis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Regions
4.2 North America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
4.3 Europe Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
4.5 South America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
5 North America Autologous Matrix-induced Chondrogenesis Revenue by Countries
5.1 North America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
5.2 USA Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
5.3 Canada Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
5.4 Mexico Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
6 Europe Autologous Matrix-induced Chondrogenesis Revenue by Countries
6.1 Europe Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
6.2 Germany Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
6.3 UK Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
6.4 France Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
6.5 Russia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
6.6 Italy Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Countries
7.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
7.2 China Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
7.3 Japan Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
7.4 Korea Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
7.5 India Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
8 South America Autologous Matrix-induced Chondrogenesis Revenue by Countries
8.1 South America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
8.2 Brazil Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
8.3 Argentina Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autologous Matrix-induced Chondrogenesis by Countries
9.1 Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
9.3 UAE Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
9.4 Egypt Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
9.5 South Africa Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Type (2015-2020)
10.2 Global Autologous Matrix-induced Chondrogenesis Market Forecast by Type (2019-2024)
10.3 Hyaluronic Acid Revenue Growth Rate (2015-2025)
10.4 Collagen Revenue Growth Rate (2015-2025)
10.5 Polyethylene Glycol (PEG) Revenue Growth Rate (2015-2025)
10.6 Poly Lactic-Co-Glycolic Acid (PGLA) Revenue Growth Rate (2015-2025)
11 Global Autologous Matrix-induced Chondrogenesis Market Segment by Application
11.1 Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2015-2020)
11.2 Autologous Matrix-induced Chondrogenesis Market Forecast by Application (2019-2024)
11.3 Knees Joint Revenue Growth (2015-2020)
11.4 Other Revenue Growth (2015-2020)
12 Global Autologous Matrix-induced Chondrogenesis Market Size Forecast (2021-2025)
12.1 Global Autologous Matrix-induced Chondrogenesis Market Size Forecast (2021-2025)
12.2 Global Autologous Matrix-induced Chondrogenesis Market Forecast by Regions (2021-2025)
12.3 North America Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
12.4 Europe Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
12.6 South America Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autologous Matrix-induced Chondrogenesis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autologous Matrix-induced Chondrogenesis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autologous Matrix-induced Chondrogenesis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autologous Matrix-induced Chondrogenesis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. JRI Orthopaedics Ltd Corporate Information, Location and Competitors
Table 6. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Major Business
Table 7. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 8. JRI Orthopaedics Ltd SWOT Analysis
Table 9. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 10. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Matricel Corporate Information, Location and Competitors
Table 12. Matricel Autologous Matrix-induced Chondrogenesis Major Business
Table 13. Matricel Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2018-2019)
Table 14. Matricel SWOT Analysis
Table 15. Matricel Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 16. Matricel Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. B. Braun Melsungen Corporate Information, Location and Competitors
Table 18. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Major Business
Table 19. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 20. B. Braun Melsungen SWOT Analysis
Table 21. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 22. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BioTissue Corporate Information, Location and Competitors
Table 24. BioTissue Autologous Matrix-induced Chondrogenesis Major Business
Table 25. BioTissue Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 26. BioTissue SWOT Analysis
Table 27. BioTissue Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 28. BioTissue Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. CartiHeal Corporate Information, Location and Competitors
Table 30. CartiHeal Autologous Matrix-induced Chondrogenesis Major Business
Table 31. CartiHeal Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 32. CartiHeal SWOT Analysis
Table 33. CartiHeal Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 34. CartiHeal Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Anika Therapeutics Corporate Information, Location and Competitors
Table 36. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Major Business
Table 37. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 38. Anika Therapeutics SWOT Analysis
Table 39. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 40. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zimmer Biomet Holdings Corporate Information, Location and Competitors
Table 42. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Major Business
Table 43. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 44. Zimmer Biomet Holdings SWOT Analysis
Table 45. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 46. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Geistlich Pharma Corporate Information, Location and Competitors
Table 48. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Major Business
Table 49. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 50. Geistlich Pharma SWOT Analysis
Table 51. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 52. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Arthro-Kinetics Corporate Information, Location and Competitors
Table 54. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Major Business
Table 55. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 56. Arthro-Kinetics SWOT Analysis
Table 57. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 58. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Smith & Nephew Corporate Information, Location and Competitors
Table 60. Smith & Nephew Autologous Matrix-induced Chondrogenesis Major Business
Table 61. Smith & Nephew Autologous Matrix-induced Chondrogenesis Total Revenue (USD Million) (2017-2018)
Table 62. Smith & Nephew SWOT Analysis
Table 63. Smith & Nephew Autologous Matrix-induced Chondrogenesis Product and Solutions
Table 64. Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Players (2015-2020)
Table 66. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Players (2015-2020)
Table 67. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Regions (2015-2020)
Table 69. North America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
Table 70. North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Table 71. Europe Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Autologous Matrix-induced Chondrogenesis Revenue by Countries (2015-2020)
Table 74. South America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Table 77. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) by Type (2015-2020)
Table 78. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Type (2015-2020)
Table 79. Global Autologous Matrix-induced Chondrogenesis Revenue Forecast by Type (2021-2025)
Table 80. Global Autologous Matrix-induced Chondrogenesis Revenue by Application (2015-2020)
Table 81. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Application (2015-2020)
Table 82. Global Autologous Matrix-induced Chondrogenesis Revenue Forecast by Application (2021-2025)
Table 83. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autologous Matrix-induced Chondrogenesis Picture
Figure 2. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type in 2019
Figure 3. Hyaluronic Acid Picture
Figure 4. Collagen Picture
Figure 5. Polyethylene Glycol (PEG) Picture
Figure 6. Poly Lactic-Co-Glycolic Acid (PGLA) Picture
Figure 7. Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application in 2019
Figure 8. Knees Joint Picture
Figure 9. Other Picture
Figure 10. Global Autologous Matrix-induced Chondrogenesis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Autologous Matrix-induced Chondrogenesis Revenue Market Share in 2019
Figure 19. Global Top 10 Players Autologous Matrix-induced Chondrogenesis Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Regions (2015-2020)
Figure 23. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Regions in 2018
Figure 24. North America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 25. Europe Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 27. South America Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 29. North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Figure 30. North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2019
Figure 31. USA Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 32. Canada Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 34. Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2019
Figure 36. Germany Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 37. UK Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 38. France Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 39. Russia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 40. Italy Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2019
Figure 43. China Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 44. Japan Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 45. Korea Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 46. India Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 48. South America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Figure 49. South America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2019
Figure 50. Brazil Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 55. UAE Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Autologous Matrix-induced Chondrogenesis Revenue and Growth Rate (2015-2020)
Figure 58. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Type (2015-2020)
Figure 59. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Type in 2019
Figure 60. Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Type (2021-2025)
Figure 61. Global Hyaluronic Acid Revenue Growth Rate (2015-2020)
Figure 62. Global Collagen Revenue Growth Rate (2015-2020)
Figure 63. Global Polyethylene Glycol (PEG) Revenue Growth Rate (2015-2020)
Figure 64. Global Poly Lactic-Co-Glycolic Acid (PGLA) Revenue Growth Rate (2015-2020)
Figure 65. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Application (2015-2020)
Figure 66. Global Autologous Matrix-induced Chondrogenesis Revenue Share by Application in 2019
Figure 67. Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Application (2021-2025)
Figure 68. Global Knees Joint Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Autologous Matrix-induced Chondrogenesis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
Figure 74. Europe Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
Figure 76. South America Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
オピオイド誘発性副作用治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Opioid Induced Side Effects Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 化学療法誘発性悪心嘔吐薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chemotherapy-induced Nausea and Vomiting Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 106.1 million by 2025, from USD 85 million in 2019…
- 化学療法誘発性末梢神経障害治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…
- 化学療法誘発性悪心嘔吐（CINV）薬の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2301630 million by 2025, from USD 1835980…
- OLEDパッシブマトリックスの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The OLED Passive Matrix market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…